[1]
A. R. PANDA and S. DAS, “CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL”, Int J Pharm Pharm Sci, vol. 16, no. 09, pp. 1–7, Sep. 2024.